Status:
COMPLETED
Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms
Lead Sponsor:
S.LAB (SOLOWAYS)
Collaborating Sponsors:
Center of New Medical Technologies
Triangel Scientific
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized, double-blind, placebo-controlled trial assessed the impact of a dietary fiber supplement (glucomannan, inulin, and psyllium) on weight and metabolic parameters in individuals with obe...
Eligibility Criteria
Inclusion
- Confirmed presence of one or more specified gene polymorphisms (FTO, MC4R, LEP, LEPR).
- Overweight or obese status (BMI ≥ 25).
Exclusion
- \- BMI \< 25
Key Trial Info
Start Date :
March 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06188832
Start Date
March 2 2022
End Date
January 18 2023
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center of New Medical Technologies
Novosibirsk, Novosibisk Region, Russia, 630090